{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:05:15Z","timestamp":1773284715313,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clinical Liver Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1002\/cld.1233","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T08:00:43Z","timestamp":1658476843000},"page":"86-89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Pneumocystis jiroveci pneumonia prophylaxis in patients with autoimmune hepatitis"],"prefix":"10.1097","volume":"20","author":[{"given":"Patrick","family":"Stauffer","sequence":"first","affiliation":[{"name":"Department of Medicine,Oregon Health & Science University,Portland,Oregon,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Ahn","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Oregon Health & Science University,Portland,Oregon,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"24","key":"cld1233-bib-0001-20241015","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"cld1233-bib-0002-20241015","first-page":"1242 e1211","article-title":"Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV\u2010negative patients","volume":"127","year":"2014","journal-title":"Am J Med"},{"issue":"1","key":"cld1233-bib-0003-20241015","article-title":"Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve\u2010year retrospective study from Norway","volume":"21","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"cld1233-bib-0004-20241015","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","year":"2008","journal-title":"Crit Care"},{"issue":"1","key":"cld1233-bib-0005-20241015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"cld1233-bib-0006-20241015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases","volume":"72","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"cld1233-bib-0007-20241015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"12","key":"cld1233-bib-0008-20241015","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","year":"2011","journal-title":"Gut"},{"issue":"RR\u20104","key":"cld1233-bib-0009-20241015","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV\u2010infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"cld1233-bib-0010-20241015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/qjmed\/91.12.813","article-title":"Clusters of Pneumocystis carinii pneumonia: analysis of person\u2010to\u2010person transmission by genotyping","volume":"91","year":"1998","journal-title":"QJM"},{"issue":"1","key":"cld1233-bib-0011-20241015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/hematology.2020000116","article-title":"Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases","volume":"2020","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"cld1233-bib-0012-20241015","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non\u2010HIV immunocompromised patients","volume":"2014","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"12b","key":"cld1233-bib-0013-20241015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/imj.12599","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014","volume":"44","year":"2014","journal-title":"Intern Med J"},{"issue":"1","key":"cld1233-bib-0014-20241015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection risk and safety of corticosteroid use","volume":"42","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"cld1233-bib-0015-20241015","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non\u2010high\u2010dose steroids\u2010clinical implication of primary prophylaxis using trimethoprim\u2010sulfamethoxazole","volume":"21","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"cld1233-bib-0016-20241015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","article-title":"Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question","volume":"77","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"cld1233-bib-0017-20241015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.090843","article-title":"A survey of rheumatologists' practice for prescribing pneumocystis prophylaxis","volume":"37","year":"2010","journal-title":"J Rheumatol"},{"issue":"6","key":"cld1233-bib-0018-20241015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cgh.2016.11.037","article-title":"Low risk of pneumonia from pneumocystis jirovecii infection in patients with inflammatory bowel disease receiving immune suppression","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"cld1233-bib-0019-20241015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jgh.14832","article-title":"Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease","volume":"35","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"cld1233-bib-0020-20241015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tid.12117","article-title":"Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort","volume":"15","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"cld1233-bib-0021-20241015","article-title":"Is routine prophylaxis against pneumocystis jirovecii needed in liver transplantation? A retrospective single\u2010centre experience and current prophylaxis strategies in Spain","volume":"9","year":"2020","journal-title":"J Clin Med"}],"container-title":["Clinical Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cld.1233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cld.1233","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.1233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T22:00:48Z","timestamp":1729029648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/cld.1233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/cld.1233","relation":{},"ISSN":["2046-2484","2046-2484"],"issn-type":[{"value":"2046-2484","type":"print"},{"value":"2046-2484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"2022-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}